Profusa Seeks Shareholder Approval for Second Reverse Split, Highly Dilutive Acquisition, and Debt Conversion Amidst Delisting Threats

summarizeSummary

Profusa is seeking shareholder approval for multiple highly dilutive proposals, including a second reverse stock split to maintain Nasdaq listing, a $30 million convertible preferred stock issuance for an acquisition, and the conversion of $1.87 million in convertible notes, alongside a significant increase in its equity incentive plan.

check_boxKey Events · Financing and Capital Events · PFSA

• Second Reverse Stock Split Proposed

  Shareholders will vote on a 1-for-5 to 1-for-200 reverse stock split to regain Nasdaq compliance, following a 1-for-75 split in February 2026 that failed to sustain the minimum bid price. This is a critical measure to avoid delisting, but often signals deep distress.

• Highly Dilutive Acquisition Financing

  Approval is sought for the issuance of $30 million in convertible preferred stock for the acquisition of PanOmics Assay assets. This represents an extremely significant dilution, exceeding 1700% of the company's current market capitalization.

• Convertible Debt Conversion to Equity

  Shareholders will vote on approving the conversion of $1.87 million in convertible notes into common stock, potentially issuing up to 5.34 million shares (over 100% of current outstanding shares) at a floor price of $0.35, to eliminate debt without using cash.

• Expanded Equity Incentive Plan

  A proposal to increase the shares available for the 2025 Equity and Incentive Plan by 695,544 shares, representing 15% of outstanding common stock, further contributing to potential dilution for existing shareholders.

auto_awesomeAnalysis · PFSA · Industrial Applications And Services

Profusa, a micro-cap company with a market capitalization of $1.72 million, is proposing a series of highly dilutive and critical measures to its shareholders. These include a second reverse stock split (1-for-5 to 1-for-200) to address ongoing Nasdaq delisting threats, a massive $30 million convertible preferred stock issuance for an acquisition (over 17 times its current market cap), and the conversion of $1.87 million in convertible notes into common stock, which could more than double the outstanding shares. Additionally, the company seeks to significantly expand its equity incentive plan by 15% of outstanding shares. These proposals collectively indicate severe financial distress and a desperate attempt to maintain listing and fund operations, with substantial negative implications for existing shareholders through extreme dilution.